Home / Drug shortages / Rifampin Injection

Rifampin Injection — FDA Drug Shortage

To Be Discontinued — Sanofi-Aventis U.S. LLC

The FDA lists a drug shortage record for Rifampin Injection (injection) from Sanofi-Aventis U.S. LLC with status To Be Discontinued. The shortage was first posted on 04/20/2026.

Shortage Details

Status
To Be Discontinued
Company
Sanofi-Aventis U.S. LLC
Package NDC
0068-0597-01
Dosage Form
Injection
Presentation
Rifadin, Injection, 600 mg/10 mL (NDC 0068-0597-01)
Initial Posting
04/20/2026
Revised Date

FDA data resources